Published in Gene Ther on April 01, 2005
TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer. Adv Cancer Res (2008) 3.63
Lighting a candle in the dark: advances in genetics and gene therapy of recessive retinal dystrophies. J Clin Invest (2010) 2.13
Photoreceptor precursors derived from three-dimensional embryonic stem cell cultures integrate and mature within adult degenerate retina. Nat Biotechnol (2013) 2.06
Novel AAV serotypes for improved ocular gene transfer. J Gene Med (2008) 1.80
Pharmacological disruption of the outer limiting membrane leads to increased retinal integration of transplanted photoreceptor precursors. Exp Eye Res (2008) 1.78
Gene therapy for retinitis pigmentosa and Leber congenital amaurosis caused by defects in AIPL1: effective rescue of mouse models of partial and complete Aipl1 deficiency using AAV2/2 and AAV2/8 vectors. Hum Mol Genet (2009) 1.76
A comprehensive review of retinal gene therapy. Mol Ther (2013) 1.70
Lentiviral gene transfer of RPE65 rescues survival and function of cones in a mouse model of Leber congenital amaurosis. PLoS Med (2006) 1.67
Regulation of PCNA and cyclin D1 expression and epithelial morphogenesis by the ZO-1-regulated transcription factor ZONAB/DbpA. Mol Cell Biol (2006) 1.65
Targeted disruption of outer limiting membrane junctional proteins (Crb1 and ZO-1) increases integration of transplanted photoreceptor precursors into the adult wild-type and degenerating retina. Cell Transplant (2010) 1.64
Targeted transgene expression in muller glia of normal and diseased retinas using lentiviral vectors. Invest Ophthalmol Vis Sci (2007) 1.28
Phagocytic clearance in neurodegeneration. Am J Pathol (2011) 1.25
Clinical characterisation of a family with retinal dystrophy caused by mutation in the Mertk gene. Br J Ophthalmol (2006) 1.24
Advances in gene therapy technologies to treat retinitis pigmentosa. Clin Ophthalmol (2013) 1.10
A novel MERTK deletion is a common founder mutation in the Faroe Islands and is responsible for a high proportion of retinitis pigmentosa cases. Mol Vis (2011) 1.05
Dynamic clonal analysis of murine hematopoietic stem and progenitor cells marked by 5 fluorescent proteins using confocal and multiphoton microscopy. Blood (2012) 1.04
The tight junction associated signalling proteins ZO-1 and ZONAB regulate retinal pigment epithelium homeostasis in mice. PLoS One (2010) 0.99
Nanoparticle applications in ocular gene therapy. Vision Res (2007) 0.98
Tyrosine-mutant AAV8 delivery of human MERTK provides long-term retinal preservation in RCS rats. Invest Ophthalmol Vis Sci (2012) 0.98
Preclinical potency and safety studies of an AAV2-mediated gene therapy vector for the treatment of MERTK associated retinitis pigmentosa. Hum Gene Ther Clin Dev (2013) 0.96
Lentiviral-vector-mediated expression of murine IL-1 receptor antagonist or IL-10 reduces the severity of endotoxin-induced uveitis. Gene Ther (2008) 0.96
Vector platforms for gene therapy of inherited retinopathies. Prog Retin Eye Res (2014) 0.94
Clinical characteristics and current therapies for inherited retinal degenerations. Cold Spring Harb Perspect Med (2014) 0.92
Gene therapy for ocular diseases. Br J Ophthalmol (2010) 0.90
Gene therapy of inherited retinopathies: a long and successful road from viral vectors to patients. Hum Gene Ther (2012) 0.90
Stem cells as tools in regenerative therapy for retinal degeneration. Arch Ophthalmol (2009) 0.89
Barriers for retinal gene therapy: separating fact from fiction. Vision Res (2008) 0.88
Nonviral ocular gene therapy: assessment and future directions. Curr Opin Mol Ther (2008) 0.85
AAV-mediated gene therapy in mouse models of recessive retinal degeneration. Curr Mol Med (2012) 0.84
A review of in vivo animal studies in retinal prosthesis research. Graefes Arch Clin Exp Ophthalmol (2008) 0.83
Transplantation of rat embryonic stem cell-derived retinal progenitor cells preserves the retinal structure and function in rat retinal degeneration. Stem Cell Res Ther (2015) 0.83
Retinal degeneration progression changes lentiviral vector cell targeting in the retina. PLoS One (2011) 0.82
C1q enhances cone photoreceptor survival in a mouse model of autosomal recessive retinitis pigmentosa. Eur J Hum Genet (2011) 0.82
Functional promoter testing using a modified lentiviral transfer vector. Mol Vis (2007) 0.81
Lentivirus-mediated RNA interference of vascular endothelial growth factor in monkey eyes with iris neovascularization. Mol Vis (2010) 0.81
Regulation of phagocytosis by TAM receptors and their ligands. Front Biol (Beijing) (2010) 0.80
AAV and compacted DNA nanoparticles for the treatment of retinal disorders: challenges and future prospects. Invest Ophthalmol Vis Sci (2011) 0.80
Using magnetic resonance imaging to assess visual deficits: a review. Ophthalmic Physiol Opt (2016) 0.79
Gene Therapy for MERTK-Associated Retinal Degenerations. Adv Exp Med Biol (2016) 0.78
Republished review: Gene therapy for ocular diseases. Postgrad Med J (2011) 0.77
Highly efficient retinal gene delivery with helper-dependent adenoviral vectors. Genes Dis (2014) 0.77
Nanoparticle-motivated gene delivery for ophthalmic application. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2015) 0.76
Cloning in single-stranded bacteriophage as an aid to rapid DNA sequencing. J Mol Biol (1980) 61.16
Sequence and organization of the human mitochondrial genome. Nature (1981) 57.39
Size and charge isomer separation and estimation of molecular weights of proteins by disc gel electrophoresis. Arch Biochem Biophys (1968) 15.05
Retinal repair by transplantation of photoreceptor precursors. Nature (2006) 6.73
DNA sequence analysis by primed synthesis. Methods Enzymol (1980) 4.75
Biochemical basis of obligate autotrophy in blue-green algae and thiobacilli. J Bacteriol (1967) 4.63
The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development. Cell (1994) 4.58
Time for a review of admission to medical school? Lancet (1995) 4.56
A dust-obscured massive maximum-starburst galaxy at a redshift of 6.34. Nature (2013) 4.43
Nitrogen chlorosis in blue-green algae. Arch Mikrobiol (1969) 4.18
Restoration of vision after transplantation of photoreceptors. Nature (2012) 3.91
A method for sequencing restriction fragments with dideoxynucleoside triphosphates. Nucleic Acids Res (1978) 3.90
Different pattern of codon recognition by mammalian mitochondrial tRNAs. Proc Natl Acad Sci U S A (1980) 3.74
Assessment of inactivated influenza-A vaccine after three outbreaks of influenza A at Christ's Hospital. Lancet (1979) 3.55
A potent synthetic peptide inhibitor of the cAMP-dependent protein kinase. J Biol Chem (1986) 3.49
Carboxyhemoglobin half-life in carbon monoxide-poisoned patients treated with 100% oxygen at atmospheric pressure. Chest (2000) 3.35
Restoration of photoreceptor ultrastructure and function in retinal degeneration slow mice by gene therapy. Nat Genet (2000) 3.00
Enhanced human cell engraftment in mice deficient in RAG2 and the common cytokine receptor gamma chain. Br J Haematol (1998) 2.97
Altered nociception, analgesia and aggression in mice lacking the receptor for substance P. Nature (1998) 2.90
MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine. Cell (1996) 2.87
Acetate assimilation by Nitrobacter agilis in relation to its "obligate autotrophy". J Bacteriol (1968) 2.74
Warm-coding deficits and aberrant inflammatory pain in mice lacking P2X3 receptors. Nature (2000) 2.73
Two genetically separable steps in the differentiation of thymic epithelium. Science (1996) 2.66
Homologous recombination between defective neo genes in mouse 3T6 cells. Cold Spring Harb Symp Quant Biol (1984) 2.65
Antibiotic prescribing for sinusitis? Br Dent J (2000) 2.55
Saphenous vein puncture for blood sampling of the mouse, rat, hamster, gerbil, guinea pig, ferret and mink. Lab Anim (1998) 2.51
The use of exonuclease III for preparing single stranded DNA for use as a template in the chain terminator sequencing method. Nucleic Acids Res (1979) 2.51
Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development. Dev Biol (2000) 2.50
Self-poisoning with drugs: a worsening situation. Br Med J (1972) 2.43
Determination of debrisoquine and its 4-hydroxy metabolite in biological fluids by gas chromatography with flame-ionization and nitrogen-selective detection. J Chromatogr (1977) 2.43
A virus from epidemic vomiting disease. Br Med J (1972) 2.26
Submillimetre galaxies reside in dark matter haloes with masses greater than 3 × 10(11) solar masses. Nature (2011) 2.21
Inhibition of N-acetylaspartate production: implications for 1H MRS studies in vivo. Neuroreport (1996) 2.18
A new redox cofactor in eukaryotic enzymes: 6-hydroxydopa at the active site of bovine serum amine oxidase. Science (1990) 2.16
Ligand-gated ion channel subunit partnerships: GABAA receptor alpha6 subunit gene inactivation inhibits delta subunit expression. J Neurosci (1997) 2.08
A crosslinked cofactor in lysyl oxidase: redox function for amino acid side chains. Science (1996) 2.06
CpG ODN-induced matrix metalloproteinase-13 expression is mediated via activation of the ERK and NF-κB signalling pathways in odontoblast cells. Int Endod J (2013) 2.03
Influenza A and meningococcal disease. Lancet (1991) 2.00
Impact of a short course in pharmacotherapy for undergraduate medical students: an international randomised controlled study. Lancet (1995) 1.97
Configuration of human dendritic cell cytoskeleton by Rho GTPases, the WAS protein, and differentiation. Blood (2001) 1.96
Influenza at Christ's Hospital: March, 1974. Lancet (1976) 1.96
In vivo gene transfer to the mouse eye using an HIV-based lentiviral vector; efficient long-term transduction of corneal endothelium and retinal pigment epithelium. Gene Ther (2001) 1.93
Why does Australia have no national drug policy? Med J Aust (1992) 1.92
The mll-AF9 gene fusion in mice controls myeloproliferation and specifies acute myeloid leukaemogenesis. EMBO J (1999) 1.88
Chemotaxis of macrophages is abolished in the Wiskott-Aldrich syndrome. Br J Haematol (1998) 1.87
Cloning and expression of cyclosporin A- and FK506-sensitive nuclear factor of activated T-cells: NF45 and NF90. J Biol Chem (1994) 1.85
CD45-null transgenic mice reveal a positive regulatory role for CD45 in early thymocyte development, in the selection of CD4+CD8+ thymocytes, and B cell maturation. J Exp Med (1996) 1.83
Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. Cancer Res (1993) 1.81
Designing new treatment strategies in vital pulp therapy. J Dent (2000) 1.80
Pharmacological disruption of the outer limiting membrane leads to increased retinal integration of transplanted photoreceptor precursors. Exp Eye Res (2008) 1.78
Reconstitution of neutrophil NADPH oxidase activity in the cell-free system by four components: p67-phox, p47-phox, p21rac1, and cytochrome b-245. J Biol Chem (1992) 1.77
Natural infection with influenza A (H3N2). The development, persistance and effect of antibodies to the surface antigens. J Hyg (Lond) (1976) 1.77
Macular hole opercula. Ultrastructural features and clinicopathological correlation. Arch Ophthalmol (1997) 1.73
Specialist phototrophs, lithotrophs, and methylotrophs: a unity among a diversity of procaryotes? Bacteriol Rev (1977) 1.72
The spectrum of skin disorders in abdominal stoma patients. Br J Dermatol (2000) 1.69
Polymorphic hydroxylation of debrisoquine. Lancet (1977) 1.69
Gene transfer into the mouse retina mediated by an adeno-associated viral vector. Hum Mol Genet (1996) 1.67
Assessment of ocular transduction using single-stranded and self-complementary recombinant adeno-associated virus serotype 2/8. Gene Ther (2007) 1.66
Gene therapy progress and prospects: the eye. Gene Ther (2006) 1.66
Targeted disruption of outer limiting membrane junctional proteins (Crb1 and ZO-1) increases integration of transplanted photoreceptor precursors into the adult wild-type and degenerating retina. Cell Transplant (2010) 1.64
The bio-availability of fluoride from black tea. J Dent (2001) 1.62
The use of a radial haemolysis test for neuraminidase antibodies in the diagnosis of influenza A infection. J Hyg (Lond) (1983) 1.60
Thiosulphate metabolism and rhodanese in Chromatium sp. strain D. J Gen Microbiol (1966) 1.60
MRP3, an organic anion transporter able to transport anti-cancer drugs. Proc Natl Acad Sci U S A (1999) 1.59
Restoration of vision in RPE65-deficient Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium. Gene Ther (2006) 1.59
Evidence-based medicine in toxicology: where is the evidence? Lancet (1996) 1.58
The microbiology of the acute dental abscess. J Med Microbiol (2009) 1.55
Wiskott-Aldrich syndrome protein is necessary for efficient IgG-mediated phagocytosis. Blood (2000) 1.53
Lymph node retrieval and assessment in stage II colorectal cancer: a population-based study. Ann Surg Oncol (2003) 1.51
Effective transplantation of photoreceptor precursor cells selected via cell surface antigen expression. Stem Cells (2011) 1.50
Barefoot doctors and the medical pyramid. Br Med J (1974) 1.49
A study of visual and blood contamination on reprocessed endodontic files from general dental practice. Br Dent J (2005) 1.49
Estrogen acutely abolishes abnormal cold-induced coronary constriction in men. Chest (1998) 1.49
Gene therapy with a promoter targeting both rods and cones rescues retinal degeneration caused by AIPL1 mutations. Gene Ther (2009) 1.48
Renal action, therapeutic use, and pharmacokinetics of the diuretic bumetanide. Clin Pharmacol Ther (1974) 1.47
Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells. Mol Ther (2001) 1.47
Stem cells and the dental pulp: potential roles in dentine regeneration and repair. Oral Dis (2007) 1.46
Gene replacement therapy in the retinal degeneration slow (rds) mouse: the effect on retinal degeneration following partial transduction of the retina. Hum Mol Genet (2001) 1.46
The Hox11 gene is essential for cell survival during spleen development. Development (1995) 1.45
Pre-sterilisation cleaning of re-usable instruments in general dental practice. Br Dent J (2007) 1.45
Chorioretinal lesions in patients and carriers of chronic granulomatous disease. J Pediatr (1999) 1.44
Inhibitory effect of the reversal agents V-104, GF120918 and Pluronic L61 on MDR1 Pgp-, MRP1- and MRP2-mediated transport. Br J Cancer (2000) 1.43
Characterization and dynamics of O-linked glycosylation of human cytokeratin 8 and 18. J Biol Chem (1992) 1.43
Ectopic retroviral expression of LMO2, but not IL2Rgamma, blocks human T-cell development from CD34+ cells: implications for leukemogenesis in gene therapy. Leukemia (2007) 1.43
Correction of SCID-X1 using an enhancerless Vav promoter. Hum Gene Ther (2011) 1.43
Neonatal dendritic cells are intrinsically biased against Th-1 immune responses. Clin Exp Immunol (2002) 1.42
Cone and rod photoreceptor transplantation in models of the childhood retinopathy Leber congenital amaurosis using flow-sorted Crx-positive donor cells. Hum Mol Genet (2010) 1.42
An immune response after intraocular administration of an adenoviral vector containing a beta galactosidase reporter gene slows retinal degeneration in the rd mouse. Br J Ophthalmol (2001) 1.42
Effects of amiloride on active sodium transport by the isolated frog skin: evidence concerning site of action. Br J Pharmacol (1970) 1.42